Sympathetic activation associated with type 2 diabetes mellitus (T2DM) is detectable even when obesity, hypertension, and metabolic syndrome are excluded, according to the results of a systematic review and meta-analysis.
Poor renal function contributes to a significant burden of disease in patients with diabetes, such that estimated glomerular filtration rate levels <90 mL/min/1.73 m2 are associated with increased mortality and cardiovascular (CV) hospitalizations, a study reports.
Menopausal women, regardless of age, are at risk of developing metabolic syndrome, as suggested in a study. The perimenopausal period may thus be an important preventive care opportunity to evaluate metabolic risk factors and improve health and longevity of women.
Treatment with levothyroxine appears to have no significant impact on systolic and diastolic heart function in older adults with mild subclinical hypothyroidism as compared with placebo, results of a study have shown.
Among middle-aged and older adults, sleeping poorly is related to general and abdominal obesity, short sleep duration to both sarcopaenic and general obesity, and depression to sarcopaenia, as suggested in a study.
Individuals who eat large amounts of vegetables and fruits, wheat, nuts, and dairy products are better protected against insulin resistance, diabetes mellitus, and excessive abdominal fat as compared with those who consume lots of fast foods, alcoholic beverages, and desserts—a dietary pattern described to promote metabolic abnormalities and disorders, as reported in a study.
At the Novartis-sponsored VERIFY Soft Launch held at Le Meridien, Kuala Lumpur, two distinguished speakers spoke on the latest updates in glucose-lowering therapy and the benefit of early treatment intensification using combination therapy (ie, vildagliptin/metformin) in the management of T2DM.